Calliditas Therapeutics

$27.00
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.30 (-1.07%) Today
-$0.20 (-0.74%) As of 10:22 AM UTC after-hours

Why Robinhood?

You can buy or sell CALT and other stocks, options, and ETFs commission-free!

About CALT

Calliditas Therapeutics AB provides pharmaceutical products for patients with niche indications. It focuses on development and commercialization of the product candidate Nefecon intended for treatment of patients with the inflammatory renal disease IgA nephropathy.

CEO
Renée Julie Elisabet Aguiar-Lucander
Employees
—
Headquarters
Stockholm, Stockholm
Founded
2004
Market Cap
679.99M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
47.53K
High Today
$27.40
Low Today
$26.76
Open Price
$27.17
Volume
11.33K
52 Week High
$38.00
52 Week Low
$19.00

CALT Earnings

-$0.45
-$0.30
-$0.15
-$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Available May 13, Pre-Market

You May Also Like

GNW
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure